GPCR (STOCKS)
Structure Therapeutics Inc. American Depositary Shares
$75.980000
-2.570000 (-3.27%)
Prev close: $78.550000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Raymond C. Stevens
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,630.18M
- Employees
- 183
- P/E (TTM)
- -21.51
- P/B (TTM)
- 6.19
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
13
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.37 | $-0.36 | -0.0116 | -3.24% |
|
Jun 2025 (Q2)
|
$-1.08 | $-0.28 | -0.7987 | -283.93% |
|
Mar 2025 (Q1)
|
$-0.81 | $-0.23 | -0.5765 | -246.90% |
|
Dec 2024 (Q4)
|
$-0.69 | $-0.23 | -0.4617 | -202.23% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $247.61M |
| Research and Development | $190.05M |
| Other Operating Expenses | $57.56M |
| Operating Income/Loss | -$247.61M |
| Income/Loss From Continuing Operations After Tax | -$210.69M |
| Income/Loss From Continuing Operations Before Tax | -$210.20M |
| Income Tax Expense/Benefit | $481.00K |
| Net Income/Loss | -$210.69M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$210.69M |
| Net Income/Loss Available To Common Stockholders, Basic | -$210.69M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.22 |
| Diluted Earnings Per Share | -$1.22 |
| Basic Average Shares | 524,829,000 |
| Diluted Average Shares | 352,482,000 |
| Assets | $832.16M |
| Current Assets | $814.02M |
| Cash | $799.00M |
| Other Current Assets | $15.02M |
| Noncurrent Assets | $18.14M |
| Fixed Assets | $4.68M |
| Other Non-current Assets | $13.46M |
| Liabilities | $62.14M |
| Current Liabilities | $57.53M |
| Accounts Payable | $17.80M |
| Wages | $8.55M |
| Other Current Liabilities | $31.18M |
| Noncurrent Liabilities | $4.61M |
| Equity | $770.02M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $770.02M |
| Liabilities And Equity | $832.16M |
| Net Cash Flow From Operating Activities | -$194.25M |
| Net Cash Flow From Operating Activities, Continuing | -$194.25M |
| Net Cash Flow From Investing Activities | $66.89M |
| Net Cash Flow From Investing Activities, Continuing | $66.89M |
| Net Cash Flow From Financing Activities | $58.14M |
| Net Cash Flow From Financing Activities, Continuing | $58.14M |
| Net Cash Flow | -$69.22M |
| Net Cash Flow, Continuing | -$69.22M |
| Comprehensive Income/Loss | -$212.70M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$212.70M |
| Other Comprehensive Income/Loss | -$2.01M |
| Other Comprehensive Income/Loss Attributable To Parent | -$2.01M |